Schnell, Oliver; Alawi, Hasan; Battelino, Tadej; Ceriello, Antonio; Diem, Peter; Felton, Anne-Marie; Harno, Kari; Satman, Ilhan; Vergès, Bruno (2014). The role of self-monitoring of blood glucose in patients treated with SGLT-2 inhibitors: a European expert recommendation. Journal of diabetes science and technology, 8(4), pp. 783-790. Diabetes Technology Society 10.1177/1932296814534366
Full text not available from this repository.The role for the novel treatment approach of sodium-glucose cotransporter-2 (SGLT-2) in type 2 diabetes is increasing. Structured self-monitoring of blood glucose (SMBG), based on a less intensive and a more intensive scheme, may contribute to an optimization of SGLT-2 inhibitor based treatment. The current expert recommendation suggests individualized approaches of SMBG, using simple and clinically applicable schemes. Potential benefits of SMBG in SGLT-2 inhibitor based treatment approaches are early assessment of treatment success or failure, timely modification of treatment, detection of hypoglycemic episodes, assessment of glucose excursions, and support of diabetes management and education. The length and frequency of SMBG should depend on the clinical setting and the quality of metabolic control.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition |
UniBE Contributor: |
Diem, Peter |
Subjects: |
600 Technology > 610 Medicine & health 500 Science > 570 Life sciences; biology |
ISSN: |
1932-2968 |
Publisher: |
Diabetes Technology Society |
Language: |
English |
Submitter: |
Peter Diem |
Date Deposited: |
26 Jun 2015 11:24 |
Last Modified: |
05 Dec 2022 14:47 |
Publisher DOI: |
10.1177/1932296814534366 |
PubMed ID: |
24876442 |
Uncontrolled Keywords: |
SGLT-2 inhibitors; SMBG; hypoglycemia; self-monitoring of blood glucose; type 2 diabetes |
URI: |
https://boris.unibe.ch/id/eprint/69001 |